STOCK TITAN

4Front Ventures Announces Brokered Offering of Up to C$5,000,100 of Units

Rhea-AI Impact
(Neutral)
Rhea-AI Sentiment
(Neutral)
Tags
Rhea-AI Summary

4Front Ventures, a vertically integrated, multi-state cannabis operator and retailer, has announced a brokered offering to sell up to 47,620,000 units at C$0.105 per unit, for gross proceeds up to C$5,000,100. Each unit includes one class A subordinate voting share and one warrant to purchase an additional share at C$0.13 within 60 months of closing. The offering, managed by Eight Capital, includes an option for agents to sell an additional 15% of the units. The units will be listed on the CSE, and the proceeds will fund equipment, inventory, cultivation inputs, retail licenses, and new retail locations. The offering closes on or around July 10, 2024, pending regulatory approvals.

Positive
  • Potential to raise up to C$5,000,100.
  • Proceeds earmarked for key operational expansions: equipment, inventory, cultivation inputs, and retail licenses.
  • Units will be listed on the CSE, enhancing liquidity.
Negative
  • Possible shareholder dilution from the issuance of 47,620,000 new units.
  • Exercise price of warrants (C$0.13) may not appeal if the stock price remains low.

PHOENIX, Ariz., June 26, 2024 /PRNewswire/ - 4Front Ventures Corp. (CSE: FFNT) (OTCQX: FFNTF) ("4Front" of the "Company"), a vertically integrated, multi-state cannabis operator and retailer, is pleased to announce that it has entered into an agreement with Eight Capital  (the "Lead Agent"), as lead agent and sole bookrunner, on behalf of a syndicate of agents to be formed (collectively with the Lead Agent, the "Agents") to act as agents on a "best efforts" basis to sell up to 47,620,000 units of the Company (the "Units") at a price of C$0.105 per Unit (the "Offering Price") for gross proceeds of up to C$5,000,100 (the "Offering").

Each Unit will consist of one class A subordinate voting share in the capital of the Company (a "SVS") and one SVS purchase warrant (each whole warrant, a "Warrant"). Each Warrant will entitle the holder thereof to purchase one additional SVS (a "Warrant Share") for a period of 60 months following the closing of the Offering at an exercise price of C$0.13 per Warrant Share. Subject to the listing requirements of the Canadian Securities Exchange (the "CSE"), it is the intention of the Company to have the Warrants listed on the CSE upon closing of the Offering.

The Company has granted the Agents an option to ‎offer for sale up to an additional 15% of the Units, at the Offering Price, ‎exercisable in ‎whole or in part at any time for a period of up to 48 hours ‎prior to the closing date of the offering (the "Agents' Option").‎

The Units are being offered and sold in this Offering pursuant to the Company's shelf registration statement on Form S-3 (No. 333-276069) declared effective by the U.S. Securities and Exchange Commission (the "SEC") on May 8, 2024 and accompanying prospectus of the same date, as further supplemented by the preliminary prospectus supplement, dated June 26, 2024‎ (collectively, the "‎U.S. Prospectus"), and pursuant to the listed issuer financing exemption from Canadian prospectus requirements under Part 5A of National Instrument 45-106 – Prospectus Exemptions (the "Listed Issuer Financing Exemption").

The Units offered under the Listed ‎Issuer Financing Exemption will not be subject to resale restrictions pursuant to applicable Canadian ‎securities laws. There is an offering document that can be accessed under the ‎Company's profile at www.sedarplus.ca and on the Company's website at - https://4frontventures.com/life-offering/. ‎Prospective investors should read this offering document before making an investment decision.‎

The closing of the Offering is subject to receipt of all necessary regulatory approvals, including the approval of the CSE. The closing of the Offering is expected to occur on or about July 10, 2024, or such other date as agreed to by the Company and the Agents.  ‎

The net proceeds of the Offering will be used to purchase equipment, inventory, cultivation inputs, and additional retail licenses and complete the buildout of the Company's new retail locations.

This press release shall not constitute an offer to sell or a solicitation of an offer to buy, nor will there be any sale of securities, in any U.S. state or other jurisdiction in which such offer, solicitation or sale would be unlawful prior to the registration or qualification under the securities laws of such U.S. state or jurisdiction. Prospective U.S. investors should read the U.S. Prospectus (including the documents incorporated by reference therein) for more complete information about the Offering and the Company, including information about the risks associated with investing in the Company. Copies of the U.S. Prospectus can be obtained by emailing the Company at IR@4frontventures.com. You may also obtain copies of these documents free of charge when they are available by visiting the SEC's EDGAR website at www.sec.gov/edgar.

About 4Front Ventures Corp.

4Front is a national, vertically integrated multi-state cannabis operator with operations in Illinois and Massachusetts and facilities in Washington.

Forward Looking Statements

This press release contains forward–looking statements and forward–looking information (collectively "forward–looking information") within the meaning of applicable securities laws.  All statements, other than statements of historical fact, included herein are forward-looking information. In addition, and without limiting the generality of the foregoing, this news release contains forward–looking information regarding: the potential Offering, the use of proceeds of the Offering, the anticipated closing date of the Offering, the exercise of the Agents' Option, the approvals required for the Offering, ‎including CSE acceptance of the Offering and the listing of the Warrants, and the size of the Offering. 

There can be no assurance that such forward-looking information will prove to be accurate. Actual results and ‎future events could differ materially from those anticipated in such forward-looking information. This forward-‎looking information reflects 4Front's current beliefs and is based on information currently available to ‎4Front and on assumptions 4Front believes are reasonable. These assumptions include but are not ‎limited to: market acceptance of the Offering; ‎CSE acceptance of the Offering; and expectations concerning prevailing commodity prices, exchange rates, interest rates, and tax laws.‎

Forward looking information is subject to known and unknown risks, uncertainties and other factors that may cause the actual results, level of activity, performance or achievements of 4Front. Such risks and other factors may include, but are not limited to: general capital market conditions and market prices for securities; delay or failure to receive board or regulatory approvals, including CSE acceptance; the actual results of future operations; general economic, political, market and business conditions; competition; the timing and availability of external financing on acceptable terms; and lack of qualified, skilled labour or loss of key individuals. A description of additional risk factors that may cause actual results to differ materially from forward-looking information can be found in 4Front's disclosure documents on the SEDAR+ website at www.sedarplus.ca and the SEC's EDGAR website at www.sec.gov/edgar. Although 4Front has attempted to identify important factors that could cause actual results to differ materially from those contained in forward-looking information, there may be other factors that cause results not to be as anticipated, estimated or intended. Readers are cautioned that the foregoing list of factors is not exhaustive. Readers are further cautioned not to place undue reliance on forward-looking information as there can be no assurance that the plans, intentions or expectations upon which they are placed will occur.

Forward-looking information contained in this news release is expressly qualified by this cautionary statement. The forward-looking information contained in this news release represents the expectations of 4Front as of the date of this news release and, accordingly, is subject to change after such date. However, 4Front expressly disclaims any intention or obligation to update or revise any forward-looking information, whether as a result of new information, future events or otherwise, except as expressly required by applicable securities law.

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/4front-ventures-announces-brokered-offering-of-up-to-c5-000-100-of-units-302183812.html

SOURCE 4Front Ventures Corp.

FAQ

What is the unit price for 4Front Ventures' (FFNTF) brokered offering announced on June 26, 2024?

The unit price for the brokered offering is C$0.105 per unit.

How much does 4Front Ventures (FFNTF) aim to raise through the brokered offering announced on June 26, 2024?

4Front Ventures aims to raise up to C$5,000,100 through the brokered offering.

What does each unit consist of in 4Front Ventures' (FFNTF) offering announced on June 26, 2024?

Each unit consists of one class A subordinate voting share and one warrant to purchase an additional share at C$0.13.

When is the closing date for 4Front Ventures' (FFNTF) brokered offering announced on June 26, 2024?

The closing date for the brokered offering is expected on or around July 10, 2024.

What will the proceeds from 4Front Ventures' (FFNTF) offering be used for?

The proceeds will be used for purchasing equipment, inventory, cultivation inputs, retail licenses, and completing new retail locations.

4FRONT VENTURES CORP

OTC:FFNTF

FFNTF Rankings

FFNTF Latest News

FFNTF Stock Data

22.75M
447.79M
51%
6.78%
Drug Manufacturers - Specialty & Generic
Healthcare
Link
United States of America
Phoenix